Systematic review and meta-analysis of efficacy and and safety or therapies in Adult Onset Still’s Disease and sJIA
IL-1i and IL-6i – highest evidence for treatment
Early (<3 months) intervention = higher rate of dz inactivity
@RheumNow #ACR23 Abs#2569 https://t.co/XzzwbLFpo7